共 174 条
[1]
Klein R(2008)The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes Ophthalmology 115 1859-1868
[2]
Knudtson MD(2009)Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients Diabetologia 52 1829-1835
[3]
Lee KE(2021)Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis Ophthalmology 128 1580-1591
[4]
Gangnon R(2006)Ocular oxygenation and the treatment of diabetic retinopathy Surv Ophthalmol 51 364-380
[5]
Klein BE(2014)Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives Trends Endocrinol Metab 25 23-33
[6]
Grauslund J(1994)Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders New England Journal of Medicine 331 1480-1487
[7]
Green A(1976)Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group Am J Ophthalmol 81 383-396
[8]
Sjolie AK(1985)Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management. Diabetic Retinopathy Vitrectomy Study (DRVS) report #1 Ophthalmology 92 492-502
[9]
Teo ZL(2017)Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial Lancet 389 2193-2203
[10]
Tham YC(2015)Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial JAMA 314 2137-2146